Stebbings, R., Findlay, L., Edwards, C., Eastwood, D., Bird, C., North, D., Mistry, Y., Dilger, P., Liefooghe, E., Cludts, I., Fox, B., Tarrant, G., Robinson, J., Meager, T., Dolman, C., Thorpe, S.J., Bristow, A., Wadhwa, M., Thorpe, R., Poole, S., 2007. "Cytokine Storm" in the Phase I Trial of Monoclonal Antibody TGN1412: Better Understanding the Causes to Improbe PreClinical Testing of Immunotherapeutics. J. Immunol. 179(5), 3325-31.
Martinez, Marilyn, N. (2011): Factors Influencing the Use and Interpretation of Animal Models in the Development of Parenteral Drug Delivery Systems. The AAPS Journal 13/4: 632-649. DOI: 10.1208/s12248-011-9303-8.
Scholz, S., Renner, P., Belanger, S. E., Busquet, F., Davi, R., Demeneix, B. A., Denny, J. S., Léonard, M., McMaster, M. E., Villeneuve, D. L., & Embry, M. R. (2013): Alternatives to in vivo tests to detect endocrine disrupting chemicals (EDCs) in fish and amphibians – screening for estrogen, androgen and thyroid hormone disruption. Critical Reviews in Toxicology 43(1): 45–72.